The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).

Zepbound, a popular weight loss drug, has become the first FDA-approved prescription medication to treat obstructive sleep ...

The first medication for obstructive sleep apnea has been approved by the U.S. Food and Drug Administration (FDA). On Dec. 20, the FDA announced that the agency has approved Eli Lilly's Zepbound ...

“Today’s approval marks the first drug treatment option for certain patients with obstructive sleep apnea,” said Sally Seymour, M.D., director of the Division of Pulmonology, Allergy, and Critical ...

Dec. 23, 2024 -- The FDA has approved the first prescription drug, Zepbound, for treating moderate to severe obstructive sleep apnea (OSA) in adults with obesity. Studies have shown that when ...

The FDA said studies have shown that by aiding weight loss, Zepbound improves sleep apnea symptoms in some patients.

The FDA has expanded the approval of Eli Lilly’s obesity medication Zepbound to include treating moderate to severe ...

The FDA approval for sleep apnea is based on ... "important risk factors for cardiovascular complications of obstructive sleep apnea with obesity," researchers wrote in the New England Journal ...

“This is a major step forward for patients with obstructive sleep apnea.” Ute Grabowsky/Photothek via Getty The FDA conducted two studies, both of which found that Zepbound helps reduce ...